Literature DB >> 3629179

Effects of additional dietary gluten on the small-intestinal mucosa of volunteers and of patients with dermatitis herpetiformis.

A Ferguson, J N Blackwell, R S Barnetson.   

Abstract

In an attempt to confirm the existence of latent coeliac disease--dose-related gluten-sensitive enteropathy--we have increased dietary gluten by 20 g daily for 2 weeks, in 6 healthy adults and 11 patients with dermatitis herpetiformis (DH). Six of the DH patients had entirely normal jejunal morphology on a normal diet. Jejunal biopsy specimens were taken before and at the end of the study. Measurements of crypts, villi, and crypt mitoses were made on microdissected specimens; disaccharidases were assayed, and intraepithelial lymphocyte counts performed. In one of the six adult volunteers, gluten loading produced diarrhoea and jejunal biopsy abnormalities. Five DH patients on a gluten-free diet had deterioration of biopsy pathology after the gluten challenge. Features suggestive of a latent gluten-sensitive enteropathy were found in one of the other six DH patients; he developed disaccharidase deficiencies and villus atrophy when 20 g gluten was added to his usual gluten-containing diet. This study supports previous suggestions that a gluten-sensitive enteropathy may be latent and dose-related.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3629179     DOI: 10.3109/00365528708991895

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  14 in total

1.  Increase in gamma/delta T cell receptor bearing lymphocytes in normal small bowel mucosa in latent coeliac disease.

Authors:  M Mäki; K Holm; P Collin; E Savilahti
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

2.  Bone mass and metabolism in dermatitis herpetiformis.

Authors:  M Di Stefano; R A Jorizzo; G Veneto; L Cecchetti; G Gasbarrini; G R Corazza
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

3.  The Oslo definitions for coeliac disease and related terms.

Authors:  Jonas F Ludvigsson; Daniel A Leffler; Julio C Bai; Federico Biagi; Alessio Fasano; Peter H R Green; Marios Hadjivassiliou; Katri Kaukinen; Ciaran P Kelly; Jonathan N Leonard; Knut Erik Aslaksen Lundin; Joseph A Murray; David S Sanders; Marjorie M Walker; Fabiana Zingone; Carolina Ciacci
Journal:  Gut       Date:  2012-02-16       Impact factor: 23.059

Review 4.  Clinical and pathological spectrum of coeliac disease--active, silent, latent, potential.

Authors:  A Ferguson; E Arranz; S O'Mahony
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

5.  Effects of gluten enriched diet on the small intestinal mucosa of normal mice and mice with graft versus host reaction.

Authors:  R Troncone; N Caputo; A Zibella; G Molitierno; L Maiuri; S Auricchio
Journal:  Gut       Date:  1994-06       Impact factor: 23.059

6.  Small intestinal function and dietary status in dermatitis herpetiformis.

Authors:  D J Gawkrodger; C McDonald; S O'Mahony; A Ferguson
Journal:  Gut       Date:  1991-04       Impact factor: 23.059

7.  Tolerance to oats in dermatitis herpetiformis.

Authors:  T Reunala; P Collin; K Holm; P Pikkarainen; A Miettinen; N Vuolteenaho; M Mäki
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

8.  Immunohistochemical changes in the jejunum in first degree relatives of patients with coeliac disease and the coeliac disease marker DQ genes. HLA class II antigen expression, interleukin-2 receptor positive cells and dividing crypt cells.

Authors:  K Holm; E Savilahti; S Koskimies; V Lipsanen; M Mäki
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

9.  Animal model of gluten induced enteropathy in mice.

Authors:  R Troncone; A Ferguson
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

10.  Lymphocytic gastritis and associated small bowel disease: a diffuse lymphocytic gastroenteropathy?

Authors:  D A Lynch; G M Sobala; M F Dixon; A Gledhill; P Jackson; J E Crabtree; A T Axon
Journal:  J Clin Pathol       Date:  1995-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.